June 29, 2017

Martin Shkreli, the founder of Turing Pharmaceutical who bought the right to Daraprim and greatly increased the price, is on trial for securities fraud. The trial begins today, and while it has nothing to do with his price gouging, his actions have made it difficult to...

June 27, 2017

The Congressional Budget Office just released its score of the Better Health Reconciliation Act, the Senate Republican health care bill. And it is not favorable! CBO determined that the bill will increase the number of people without health insurance by 22 million by 2...

June 23, 2017

The Senate Republican healthcare bill, called the Better Care Reconciliation Act, would dramatically transform the nation’s healthcare system, and not for the better. The 142 page bill creates a new system of tax credits to help people purchase health insurance but mak...

June 22, 2017

At long last, Senate Majority Leader Mitch McConnell has released the Senate version of the health care bill. And frankly, it is a terrible bill that will harm millions of Americans: it will end the mandate that most Americans have health insurance, deeply cut Medicaid...

June 20, 2017

Even the most stubborn companies—drug manufacturers and pharmacy benefit managers—are now acknowledging that high drug prices are a big problem. It is clear that half measures will no longer help struggling patients. What we need is substantive, meaningful reform that...

June 19, 2017

Pharmacy benefit managers (PBMs) have recently been getting more attention and scrutiny for the role they play in increasing drug costs. This is quite welcome; for far too long these organizations have operated under the radar, despite their misbehavior and the lack of...

June 16, 2017

Yesterday consumer advocates and unions won a sweeping victory in Nevada. SB 539, a bill to reduce the prices of drugs used to treat diabetes, was signed by Governor Brian Sandoval into law. This bill requires greater transparency and accountability for both drug compa...

June 13, 2017

This morning the Senate Health, Education, Labor, and Pensions Committee held the first of three hearings on high drug prices. A great many Democratic Senators attended, and the hearing focused on outrageous drug costs and patient complaints. This is further evidence t...

June 9, 2017

With all the talk of supply chains and companies and finger pointing, the people hurt by high drug costs are often forgotten or obscured. Thankfully, that has recently been changing as more and more patients and consumers tell their stories about drugs that they cannot...

June 9, 2017

The evidence against pharmacy benefit managers (PBMs) just keeps piling up. A new report by Merrill Matthews and Peter Pitts of the Institute for Policy Innovation examines price transparency in the health care market, and concludes that PBMs reap gigantic profits and...

Please reload

Featured Posts

United States-Mexico-Canada Agreement (USMCA)

October 5, 2018

1/4
Please reload

Recent Posts
Please reload

Archive